ModernVivo
AI-powered platform for designing preclinical drug discovery studies.
ModernVivo is a biotech & life sciences company based in Seattle, US, founded in 2022. It has raised $1 million in disclosed funding. Its latest round was a Pre-seed of $1 million in September 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $1M across 1 round. Computed only from sourced rounds.
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| $1M | Pre-seed | — | — | Biotech & Life Sciences | 1 |
- ModernVivo$1M
Questions and answers
What does ModernVivo do?
AI-powered platform for designing preclinical drug discovery studies.
How much has ModernVivo raised?
ModernVivo has raised $1 million in disclosed funding across 1 round tracked by OSH.
When and where was ModernVivo founded?
ModernVivo was founded in 2022 and is based in Seattle, US.
Timeline
Founded
Sources
- 1.Fewer lab animals, better drugs: This startup wants to fix how experiments get designed — GeekWire, Sep 18, 2026